36 results
425
THER
Theralink Technologies, Inc.
26 May 23
Business combination disclosure
5:14pm
in the Merger, (vi) subject to specified materiality standards, the accuracy of the representations and warranties of the other party, (vii) the authorization … of establishing these matters as facts; and may be subject to standards of materiality applicable to the contracting parties that differ from those
425
EX-2.1
THER
Theralink Technologies, Inc.
26 May 23
Business combination disclosure
5:14pm
” and “material to Parent” shall refer to materiality relating to the Company or Parent, as applicable, and to the business of the Company or of Parent
8-K
5jav7
26 May 23
Theralink® Signs Definitive Merger Agreement to be Acquired by
5:11pm
8-K
EX-2.1
stjvenjv
26 May 23
Theralink® Signs Definitive Merger Agreement to be Acquired by
5:11pm
8-K
EX-10.2
y7rpzuwk0v0x5k pz557
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
8-K
EX-10.1
t70d0
3 Feb 22
Entry into a Material Definitive Agreement
5:11pm
8-K
EX-10.1
qdajtfge
5 Nov 21
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.1
mh0z zt5p3f
6 Aug 21
Entry into a Material Definitive Agreement
4:50pm
8-K
EX-3.1
0itixrdk9nhge
6 Aug 21
Entry into a Material Definitive Agreement
4:50pm
8-K
EX-10.1
ggfkz0
19 May 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
c1xce zog87dzn9wl0u
22 Sep 20
Entry into a Material Definitive Agreement
12:00am
DEFM14C
21bmu915u9z 1h8a0
31 Aug 20
Information related to merger
7:00am
PREM14C
wblamb by
19 Aug 20
Preliminary information related to merger
4:41pm
8-K
EX-3.1
5gte74dv82elo
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-3.2
3m1yk hsezziv0
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
z1e7kenh7
13 May 20
Entry into a Material Definitive Agreement
5:10pm